PatientsVille.com Logo

PatientsVille

Nabumetone Side Effects

Common Nabumetone Side Effects


The most commonly reported Nabumetone side effects (click to view or check a box to report):

Diarrhoea (15)
Nausea (10)
Dyspnoea (10)
Abdominal Pain Upper (9)
Abdominal Pain (9)
Dizziness (8)
Rash (8)
Urticaria (7)
Vomiting (7)
Oedema Peripheral (7)
Pruritus (6)
Chest Pain (6)
Anxiety (6)
Pain (5)
Blister (5)
Dyspepsia (5)
Completed Suicide (5)
Constipation (5)
Abdominal Discomfort (5)
Flatulence (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Nabumetone Side Effects Reported to FDA

The following Nabumetone reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Nabumetone on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Faeces Discoloured
This is a report of a 75-year-old male patient (weight: NA) from US, suffering from the following symptoms/conditions: muscle strain, who was treated with Nabumetone (dosage: NA, start time: Sep 25, 2013), combined with:
  • Omeprazole
  • Amoxicillin
  • Metronidazole
  • Centrum
  • Vitamin C
  • Vitamin E
and developed a serious reaction and side effect(s). The consumer presented with:
  • Faeces Discoloured
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Nabumetone treatment in male patients, resulting in faeces discoloured side effect.

Hypersensitivity, Myocardial Infarction
This report suggests a potential Nabumetone Hypersensitivity, Myocardial Infarction side effect(s) that can have serious consequences. A 53-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: arthralgia and used Nabumetone (dosage: 1 Twice Daily) starting Jun 23, 2013. Soon after starting Nabumetone the patient began experiencing various side effects, including:
  • Hypersensitivity
  • Myocardial Infarction
Drugs used concurrently: NA.The patient was hospitalized. Although Nabumetone demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hypersensitivity, may still occur.

Diarrhoea, Hypoacusis
This Diarrhoea, Hypoacusis problem was reported by a pharmacist from US. A 85-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: intervertebral disc protrusion. On Jun 24, 2013 this consumer started treatment with Nabumetone (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Nabumetone, the patient experienced the following unwanted symptoms/side effects:
  • Diarrhoea
  • Hypoacusis
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as diarrhoea, may become evident only after a product is in use by the general population.

Hypoacusis
This is a report of a 85-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Nabumetone (dosage: 1500 Milligram Daily;) starting Jun 24, 2013. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Hypoacusis
This opens a possibility that Nabumetone treatment could cause the above reactions, including hypoacusis, and some female subjects may be more susceptible.


Pain In Extremity
A 62-year-old female patient (weight: NA) from US with the following symptoms/conditions: NA started Nabumetone treatment (dosage: 1 Tablet Kaiser) on NS. Soon after starting Nabumetone treatment, the subject experienced various side effects, including:
  • Pain In Extremity
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Nabumetone.

Chronic Obstructive Pulmonary Disease
A 73-year-old female patient from GB (weight: NA) experienced symptoms, such as: rheumatoid arthritis and was treated with Nabumetone(dosage: NA). The treatment was initiated on Nov 07, 2003. After that a consumer reported the following side effect(s):
  • Chronic Obstructive Pulmonary Disease
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Nabumetone efficacy: NA.The patient was hospitalized.

Coma, Hepatic Failure, Hypothermia, Depressed Level Of Consciousness, Overdose
In this report, Nabumetone was administered for the following condition: rheumatoid arthritis.A 46-year-old female consumer from GB (weight: NA) started Nabumetone treatment (dosage: NA) on Mar 28, 2013.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Coma
  • Hepatic Failure
  • Hypothermia
  • Depressed Level Of Consciousness
  • Overdose
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Nabumetone treatment could be related to the listed above side effect(s).

Pain, Product Substitution Issue
This is a report of the following Nabumetone side effect(s):
  • Pain
  • Product Substitution Issue
A male patient from US (weight: NA) presented with the following condition: NA and received a treatment with Nabumetone (dosage: 500 Mg Am + Hs, Oral) starting: Mar 22, 2011.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Nabumetone treatment could be associated with the listed above side effect(s).

Oedema Peripheral, Chest Discomfort
This Nabumetone report was submitted by a 33-year-old female consumer from US (weight: NA). The patient was diagnosed with: NA and Nabumetone was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Oedema Peripheral
  • Chest Discomfort
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Nabumetone treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Abnormal Dreams
This is a report of a possible correlation between Nabumetone use and the following symptoms/side effect(s):
  • Abnormal Dreams
which could contribute to an assessment of Nabumetone risk profile.A female consumer from UNITED STATES (weight: NA) was suffering from arthritis and was treated with Nabumetone (dosage: 500 Mg, 2x/day) starting May 01, 2012.Other concurrent medications:
  • Chantix (0.5 Mg, Daily)
  • Zetia (10 Mg, Daily)
  • Oxybutynin (5 Mg, 2x/day)
  • Chantix (0.5 Mg, 2x/day)
  • Effexor (75 Mg, Daily)
  • Allegra (Unk, As Needed)
  • Benazepril (20/25mg, Daily)
  • Flexeril (10 Mg, Daily)


Arthralgia, Pyrexia
A male patient from (weight: NA) presented with the following symptoms: NA and after a treatment with Nabumetone (dosage: NA) experienced the following side effect(s):
  • Arthralgia
  • Pyrexia
The treatment was started on Mar 14, 2012. Nabumetone was used in combination with the following drugs:
  • Prednisone Tab
  • Prednisone Tab
  • Incivek
  • Pegasys
  • Zoloft
  • Oxycodone Hcl
  • Ribavirin
This report could alert potential Nabumetone consumers.

Breast Cancer, Breast Inflammation, Breast Pain, Gynaecomastia, Breast Mass
In this report, a 65-year-old male patient from SPAIN (weight: NA) was affected by a possible Nabumetone side effect.The patient was diagnosed with inflammation. After a treatment with Nabumetone (dosage: NA, start date: Nov 14, 2010), the patient experienced the following side effect(s):
  • Breast Cancer
  • Breast Inflammation
  • Breast Pain
  • Gynaecomastia
  • Breast Mass
The following simultaneously used drugs could have led to this reaction:
  • Omeprazole
  • Avodart (1cap Per Day)
The findings here stress that side effects should be taken into consideration when evaluating a Nabumetone treatment.

Fall, Pain In Extremity, Stress Fracture, Fracture Delayed Union, Femur Fracture, Fracture Displacement
This is a report of a 57-year-old female patient from UNITED STATES (weight: NA), who used Nabumetone (dosage: NA) for a treatment of NA. After starting a treatment on May 01, 2009, the patient experienced the following side effect(s):
  • Fall
  • Pain In Extremity
  • Stress Fracture
  • Fracture Delayed Union
  • Femur Fracture
  • Fracture Displacement
The following drugs could possibly have interacted with the Nabumetone treatment
  • Vitamin D (colecalciferol)
  • Folic Acid
  • Clarinex (loratadine, Pseudoephedrine Sulfate)
  • Actonel (150 Mg Once Monthly, Oral)
  • Ferrous Sulfate Tab
  • Pantoprazole Sodium (pantoprazole Sodium Sesquihydrate)
  • Aspirin
  • Nasonex
The patient was hospitalized.Taken together, these observations suggest that a Nabumetone treatment could be related to side effect(s), such as Fall, Pain In Extremity, Stress Fracture, Fracture Delayed Union, Femur Fracture, Fracture Displacement.

Superior Sagittal Sinus Thrombosis
This superior sagittal sinus thrombosis side effect was reported by a health professional from UNITED STATES. A 18-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Nabumetone (dosage: Unk), which was started on Feb 01, 2011. Concurrently used drugs:
  • Singulair (10 Mg, Every Evening)
  • Singulair (5mg Daily)
  • Promethazine (Unk)
  • Yaz
  • Tramadol Hydrochloride (Unk)
When starting to take Nabumetone the consumer reported the following symptoms:
  • Superior Sagittal Sinus Thrombosis
The patient was hospitalized. These side effects may potentially be related to Nabumetone.

Migraine, Pain, Malaise, Weight Increased
This is a Nabumetone side effect report of a female patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: pain,fibromyalgia, who was treated with Nabumetone (dosage:Unk, start time: Aug 01, 2011), combined with:
  • Lyrica (100 Mg, 2x/day)
, and developed a serious reaction and a migraine side effect. The patient presented with:
  • Migraine
  • Pain
  • Malaise
  • Weight Increased
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Nabumetone treatment in female patients suffering from pain,fibromyalgia, resulting in migraine.

Shock Haemorrhagic, Upper Gastrointestinal Haemorrhage
This report suggests a potential Nabumetone shock haemorrhagic side effect(s) that can have serious consequences. A 57-year-old female patient from FRANCE (weight:NA) was diagnosed with the following health condition(s): bone pain and used Nabumetone (dosage: 2g Twice Per Day) starting Mar 01, 2012. Soon after starting Nabumetone the patient began experiencing various side effects, including:
  • Shock Haemorrhagic
  • Upper Gastrointestinal Haemorrhage
Drugs used concurrently:NA. The patient was hospitalized. Although Nabumetone demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as shock haemorrhagic, may still occur.

Angioedema, Urticaria
This angioedema problem was reported by a health professional from FRANCE. A 36-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): neck pain.On Jan 15, 2011 a consumer started treatment with Nabumetone (dosage: 500mg Per Day). The following drugs/medications were being taken at the same time: NA. When commencing Nabumetone, the patient experienced the following unwanted symptoms /side effects:
  • Angioedema
  • Urticaria
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as angioedema, may become evident only after a product is in use by the general population.

Deafness Neurosensory, Tinnitus, Deafness Unilateral, Nephrolithiasis
This is a Nabumetone side effect report of a female patient (weight: NA) from KOREA, REPUBLIC OF. The patient developed the following symptoms/conditions: NA and was treated with Nabumetone (dosage: NA) starting Apr 01, 2009. Concurrently used drugs:
  • Amlodipine
  • Rebamipide
  • Deflazacort
  • Methotrexate
  • Golimumab
  • Golimumab
  • Golimumab
  • Methotrexate
Soon after that, the consumer experienced the following of symptoms:
  • Deafness Neurosensory
  • Tinnitus
  • Deafness Unilateral
  • Nephrolithiasis
The patient was hospitalized. This opens a possibility that Nabumetone could cause deafness neurosensory and that some female patients may be more susceptible.

Cerebrovascular Accident, Subdural Haematoma
A male patient (weight: NA) from UNITED STATES with the following symptoms: osteoarthritis,malignant melanoma,hypertension started Nabumetone treatment (dosage: NA) on Oct 31, 2011. Soon after starting Nabumetone treatment, the consumer experienced several side effects, including:
  • Cerebrovascular Accident
  • Subdural Haematoma
. Concurrently used drugs:
  • Zelboraf
  • Chlorthalidone
  • Losartan Potassium
  • Allopurinol
  • Labetalol Hcl
This finding indicates that some patients can be more vulnerable to developing Nabumetone side effects, such as cerebrovascular accident.

White Blood Cell Count Increased, Flatulence, Constipation, Sleep Disorder
This white blood cell count increased side effect was reported by a consumer or non-health professional from UNITED STATES. A female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Nabumetone (dosage: Unk), which was started on Feb 29, 2012. Concurrently used drugs:
  • Chantix (Unk)
  • Atorvastatin (Unk)
  • Tramadol (Unk)
  • Clonazepam (Unk)
  • Vitamin B-12 (Unk)
  • Ambien (Unk)
  • Chantix (0.5 Mg, 1x/day)
  • Synthroid (Unk)
.When starting to take Nabumetone the consumer reported symptoms, such as:
  • White Blood Cell Count Increased
  • Flatulence
  • Constipation
  • Sleep Disorder
These side effects may potentially be related to Nabumetone.

Vomiting, Headache
This is a report of a 45-year-old female patient (weight: NA) from FRANCE, suffering from the following symptoms/conditions: NA, who was treated with Nabumetone (dosage: NA, start time: Apr 15, 2011), combined with:
  • Prednisone Tab
  • Cyclophosphamide
  • Methotrexate Sodium
  • Potassium Chloride
  • Torental
  • Folic Acid
  • Esomeprazole Sodium
  • Calcium Carbonate
and developed a serious reaction and side effect(s). The consumer presented with:
  • Vomiting
  • Headache
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Nabumetone treatment in female patients, resulting in vomiting side effect. The patient was hospitalized.

Gastrooesophageal Reflux Disease, Renal Failure Acute, Abdominal Discomfort
This report suggests a potential Nabumetone Gastrooesophageal Reflux Disease, Renal Failure Acute, Abdominal Discomfort side effect(s) that can have serious consequences. A 35-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: arthralgia and used Nabumetone (dosage: 750 Mg) starting NS. Soon after starting Nabumetone the patient began experiencing various side effects, including:
  • Gastrooesophageal Reflux Disease
  • Renal Failure Acute
  • Abdominal Discomfort
Drugs used concurrently: NA.The patient was hospitalized and became disabled. Although Nabumetone demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as gastrooesophageal reflux disease, may still occur.

Injection Site Haematoma
This Injection Site Haematoma problem was reported by a consumer or non-health professional from UNITED STATES. A 54-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Sep 09, 2011 this consumer started treatment with Nabumetone (dosage: NA). The following drugs were being taken at the same time:
  • Folic Acid
  • Humira
When commencing Nabumetone, the patient experienced the following unwanted symptoms/side effects:
  • Injection Site Haematoma
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as injection site haematoma, may become evident only after a product is in use by the general population.

Injection Site Pain
This is a report of a 64-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Nabumetone (dosage: NA) starting Oct 01, 2009. Concurrently used drugs:
  • Oxybutynin Chloride (1 Packet Daily)
  • Humira
  • Calcium With D
  • Multi-vitamin
  • Methotrexate (Weekly)
  • Folic Acid
  • Iron (Daily)
Soon after that, the consumer experienced the following side effects:
  • Injection Site Pain
This opens a possibility that Nabumetone treatment could cause the above reactions, including injection site pain, and some male subjects may be more susceptible.

Papule, Urticaria, Wound Secretion
A male patient (weight: NA) from UNITED STATES with the following symptoms/conditions: psoriatic arthropathy,diabetes mellitus,multiple sclerosis,osteoarthritis,psoriasis,blood cholesterol increased started Nabumetone treatment (dosage: NA) on Feb 01, 2011. Soon after starting Nabumetone treatment, the subject experienced various side effects, including:
  • Papule
  • Urticaria
  • Wound Secretion
Concurrently used drugs:
  • Metformin Hcl
  • Tizanidine Hcl
This finding indicates that some male patients could be more vulnerable to Nabumetone.

1 of 6 



Top 10 Nabumetone Side Effects for Women

Women Side EffectsReports
Diarrhoea 13
Dyspnoea 9
Nausea 9
Abdominal Pain 8
Rash 7
Abdominal Pain Upper 6
Anxiety 6
Chest Pain 6
Vomiting 6
Oedema Peripheral 5

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Nabumetone Side Effects

    Did You Have a Nabumetone Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Nabumetone for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Nabumetone Safety Alerts, Active Ingredients, Usage Information

    NDC0093-1015
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameNabumetone
    NameNabumetone
    Dosage FormTABLET, FILM COATED
    RouteORAL
    On market since20010820
    LabelerTeva Pharmaceuticals USA Inc
    Active Ingredient(s)NABUMETONE
    Strength(s)500
    Unit(s)mg/1
    Pharma ClassCyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonst

    Nabumetone Dosage, Warnings, Usage.

    Side Effects reported to FDA: 150

    Nabumetone safety alerts: No

    Reported deaths: 10

    Reported hospitalizations: 65

    Latest Nabumetone clinical trials